Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hsu

Showing results (1201-1210 of 1,368) with videos related to

Pageof 137
Sort By:
Radiation Research|November 26, 2008
Prevalence of adult-onset multifactorial disease among offspring of atomic bomb survivorsS Fujiwara, A Suyama, J B Cologne, et al.
Nature Nanotechnology|June 27, 2017
Sulfated glycopeptide nanostructures for multipotent protein activationSungsoo S Lee, Timmy Fyrner, Feng Chen, et al.
Journal of Leukocyte Biology|November 22, 2019
Distinguishing human peripheral blood CD16<sup>+</sup> myeloid cells based on phenotypic characteristicsPhillip D Fromm, Pablo A Silveira, Jennifer L Hsu, et al.
Signal Transduction and Targeted Therapy|April 17, 2025
RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancerZhengyu Zha, Chunxiao Liu, Meisi Yan, et al.
Cancer Research|October 21, 2016
Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated MethylationYan Wang, Jung-Mao Hsu, Ya'an Kang, et al.
Cancer Research|June 28, 2014
Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancerYi-Hsin Hsu, Jun Yao, Li-Chuan Chan, et al.
Biomaterials|October 25, 2023
A supramolecular polymer-collagen microparticle slurry for bone regeneration with minimal growth factorMark T McClendon, Wei Ji, Allison C Greene, et al.
Blood Advances|September 22, 2023
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell diseaseJane S Hankins, Donald Brambilla, Michael B Potter, et al.
Theranostics|October 12, 2020
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progressionChing-Chan Lin, Yu-Kai Huang, Chia-Fong Cho, et al.
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
Pageof 137

Showing results (1201-1210 of 1,368) with videos related to

Sort By:
Pageof 137
Radiation Research|November 26, 2008
Prevalence of adult-onset multifactorial disease among offspring of atomic bomb survivorsS Fujiwara, A Suyama, J B Cologne, et al.
Nature Nanotechnology|June 27, 2017
Sulfated glycopeptide nanostructures for multipotent protein activationSungsoo S Lee, Timmy Fyrner, Feng Chen, et al.
Journal of Leukocyte Biology|November 22, 2019
Distinguishing human peripheral blood CD16<sup>+</sup> myeloid cells based on phenotypic characteristicsPhillip D Fromm, Pablo A Silveira, Jennifer L Hsu, et al.
Signal Transduction and Targeted Therapy|April 17, 2025
RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancerZhengyu Zha, Chunxiao Liu, Meisi Yan, et al.
Cancer Research|October 21, 2016
Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated MethylationYan Wang, Jung-Mao Hsu, Ya'an Kang, et al.
Cancer Research|June 28, 2014
Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancerYi-Hsin Hsu, Jun Yao, Li-Chuan Chan, et al.
Biomaterials|October 25, 2023
A supramolecular polymer-collagen microparticle slurry for bone regeneration with minimal growth factorMark T McClendon, Wei Ji, Allison C Greene, et al.
Blood Advances|September 22, 2023
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell diseaseJane S Hankins, Donald Brambilla, Michael B Potter, et al.
Theranostics|October 12, 2020
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progressionChing-Chan Lin, Yu-Kai Huang, Chia-Fong Cho, et al.
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
Pageof 137